Key result
Intermittent intravenous administration of Iloprost significantly decreased functional class, pulmonary pressures, and NT-proBNP, and increased 6-minute walk distance in patients with IPAH.
Why the study?
Does intermittent intravenous administration of Iloprost improve functional class, hemodynamics, and NT-proBNP in patients with idiopathic pulmonary arterial hypertension?
Observational (n=20)
Does intermittent intravenous administration of Iloprost improve functional class, hemodynamics, and NT-proBNP in patients with idiopathic pulmonary arterial hypertension?
Intermittent intravenous Iloprost over 12 months improves functional class, hemodynamics, and exercise capacity in patients with idiopathic pulmonary arterial hypertension.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Malekmohammad et al. (2016) conducted an observational in Idiopathic pulmonary arterial hypertension (IPAH) (n=20). Intermittent intravenous Iloprost was evaluated on NYHA/WHO functional classification, 6-minute walk test, mean pulmonary arterial pressure, right ventricular pressure, and NT-proBNP. Intermittent intravenous administration of Iloprost significantly decreased functional class, pulmonary pressures, and NT-proBNP, and increased 6-minute walk distance in patients with IPAH.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: